22nd Century Group (XXII)

[admin]

At the minimum, the SA short article on XXII raises a number of questions, in no particular order (and no intention to be complete):

1. Why not sell Red Sun and Magic as a non (MSA) participating member? (the article mention other small companies do this, without mentioning them by name).
2. Earlier efforts to sell Red Sun and Magic haven't exactly been successful. At the minimum, it needs big expenditures in marketing.
3. Why has XXII acquired NASCO to get MSA membership while they had their own application and the procedures are essentially the same (according to the article)?
4. Earlier (2011) clinical trial failure of X22, why would they be successful this time around?
5. Suspension of new clinical trials, what is the prospect of continuation?
6. BAT's development plan doesn't include low nicotine cigarettes?
7. What is the status of the license of the patents from North Carolina State University? Article puts these in doubt.
8. The failure of Vector's Quest cigarettes based on the same patents isn't exactly reassuring. Is there a significant difference between Magic and Quest?

We're not saying there are no satisfactory answers to these (and others), what ww do say is that anyone confident on holding or buying should at least be able to answer these with some degree of confidence.